Voice, Dyspnea and Acute Respiratory Failure
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Jun 2025
- Ended
- 1 Sept 2026
- Type of study
- Interventional
- Treatments tested
- Voice registration
- Record updated
- 2 October 2024
- Why it stopped
- study discontinued
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- patients hospitalised in the Pitié-Salpêtrière Pneumology Department with an acute respiratory illness (pneumonia of any cause, COVID pneumonia depending on the epidemic context, COPD decompensation, etc)
- whose condition allows conversational exchanges with the nursing staff within the framework of usual care
- adults, not protected
- understand and speak French fluently
- affiliated to the social security system
- having read and understood the information leaflet
- do not object to the use of their data
Who cannot take part
- a clinical condition on admission that is too severe to allow the patient to answer the usual questions of the anamnestic and clinical examination
- patients with neurological, otorhinolaryngological or psychiatric pathology
- patients with uncorrected hearing problems
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Breathing is an automatic vital function that has the peculiarity of being controllable voluntary for actions other than breathing. Speech production is a characteristic example of use of the respiratory system for nonrespiratory purposes. A healthy respiratory system is necessary for speech to be adequately produced and modulated. In patients with respiratory diseases, it becomes difficult to interfere with an automatic control of breathing that is intensely active to compensate for the respiratory deficience. Speech production is impeded, and, reciprocally, speech can generate dyspnea. This study explores the hypothesis that longitudinal changes in speech characteristics will parallel the clinical evolution of acute respiratory episodes. The aim is to validate such changes as prognostic indicators, in the perspective of future telemedicine applications. The hypothesis tested is that of an association between :
Read full original descriptionShow less
* vocal abnormalities at inclusion (assessed in relation to known data within a normal population (database of holy subjects already constituted) and the initial clinical severity (assessed according to the usual clinical and gasometric criteria): * the evolution of vocal abnormalities during the stay and the clinical evolution.
The group in the trial
- Arm 1Treatment being tested
intervention correspond to the voice registration
Treatment: Voice registration
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Speech and Voice As Biomarkers of Physiological Status in Patients with Respiratory Diseases: Proof of Concept in Acute Respiratory Disease Managed in a Pulmonary Hospital
- Record updated
- 2 October 2024